Advertisement
Research Article| Volume 12, ISSUE 4, P835-844, December 1992

Regulatory and Legislative Issues in Transfusion Medicine

      This paper is only available as a PDF. To read, Please Download here.
      The blood supply in the United States is safer than ever, following implementation of more restrictive donor screening and additional tests for infectious agents. Because of AIDS, however, there is a heightened awareness that blood transfusion is not an entirely benign therapy. Increased public concern about disease transmission through blood transfusion has led to closer monitoring of blood banks by federal regulatory agencies and more interaction between the agencies and Congress on blood- related issues. Regulatory and legislative issues in transfusion medicine also are described in this article.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • American Association of Blood Banks
        AABB establishes quality assurance committees.
        Blood Bank Week. 1991; 8: 1-2
        • Centers for Disease Control: Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B to health-care and public-safety workers
        MMWR. 1989; 38 (no. S-6)
        • Centers for Disease Control: Public Health Service interagency guidelines for screening donors of blood, plasma, organs, tissues and semen for evidence of hepatitis B and hepatitis C
        MMWR. 1991; 40 (no. RR-4)
        • Code of Federal Regulations, current edition: Title 21 CFR-Food and Drugs. Parts 7, 10, 211, 312, 600-660, 820
        US Government Printing Office, Washington, DC1992
        • Code of Federal Regulations, current edition: Title 29 CFR-Labor. Parts 1903-4, 1910
        US Government Printing Office, Washington, DC1991
        • Code of Federal Regulations, current edition: Title 39 CFR-Postal Service. Part 111
        US Government Printing Office, Washington, DC1990
        • Code of Federal Regulations, current edition: Title 40 CFR-Environmental Protection Agency. Chapter I
        US Government Printing Office, Washington, DC1989
        • Code of Federal Regulations, current edition: Title 42 CFR-Public Health. Parts 72, 74, 85, 405, 493
        US Government Printing Office, Washington, DC1990
        • Code of Federal Regulations, current edition: Title 49 CFR-Transportation. Parts 172- 173
        US Government Printing Office, Washington, DC1990
        • Faustus B.
        The therapy of the Cook County Hospital.
        JAMA. 1937; 109: 128-131
        • Food and Drug Administration
        Blood Bank Inspection Checklist and Report, with Instruction Booklet.
        Office of Compliance/Center for Biologies Evaluation and Research, Rockville, MD1991
      1. Food and Drug Administration: Memoranda to all Registered Blood Establishments. Office of Compliance/Center for Biologies Evaluation and Research, Rockville, MD1981-1982
      2. Jones F.W. Accreditation Requirements Manual. ed 4. American Association of Blood Banks, Bethesda, MD1992
        • Occupational Safety and Health Administration: OSHA Instruction CPL 2-2.44B
        Office of Health Compliance Assistance/Occupational Safety and Health Administration, Washington, DC1990
      3. Otter J. Regulatory Resource Manual. American Association of Blood Banks, Arlington, VA1991
      4. Schaeffer M. Federal Legislation and the Clinical Laboratory. GK Hall Medical Publishers, Boston, MA1981
      5. United States Code: Federal Food, Drug, and Cosmetic Act. Title 21 USC. Washington, DC, US Government Printing Office

      6. United States Code: Freedom of Information Act. Title 5 USC, section 552. Washington, DC, US Government Printing Office

      7. United States Code: Public Health Service Act. Title 42 USC. Washington, DC, US Government Printing Office

        • United States Congress, Committee on Government Operations
        A Citizen’s Guide on Using the Freedom of Information Act and the Privacy Act of 1974 to Request Government Records. US Government Printing Office, Washington, DC1989
      8. Walker R.H. Technical Manual. ed 10. American Association of Blood Banks, Arlington, VA1990
      9. Widmann F.K. Standards for Blood Banks and Transfusion Services. ed 14. American Association of Blood Banks, Arlington, VA1991
        • Ziporyn T.
        The Food and Drug Administration: How Those regulations’ came to be.
        JAMA. 1985; 254: 2037-2046